Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy

Journal of Intensive Care Medicine

Volumn 20, Issue 6, 2005, Pages 279-285

  Khouli, Hassan ^a,c   Afrasiabi, Ardavan ^a   Shibli, Muhamad ^a   Hajal, Rizan ^a   Barrett, C Redington ^a   Homel, Peter ^b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Admissions with HIV related illness; AIDS; Highly active antiretroviral therapy (HAART); Mechanical ventilation; Outcome; Prophylaxis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTIFICIAL VENTILATION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CRITICAL ILLNESS; DEMOGRAPHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

EID: 30944457284     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066605281087     Document Type: Review

References (35)

1. De Palo VA, Millstein BH, Mayo PH, et al. Outcome of intensive care in patients with HIV infection. Chest. 1995;107:506-510.
2. Rosen MJ, Clayton K, Schneider RF, et al. Intensive care of patients with HIV infection: utilization, critical illness, and outcome. Am J Respir Crit Care Med. 1997;155:67-71.
3. Curtis JR, Greenberg DL, Hudson LD, et al. Changing use of intensive care for HIV-infected patients with pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 1994;150:1305-1310.
4. Watcher R, Luce JM, Safrin S, et al. Cost and outcome of intensive care for patients with AIDS, pneumocystis carinii pneumonia, and severe respiratory failure. JAMA. 1995;273:230-235.
5. Murray JF, Felton CP, Garay SM, et al. Pulmonary complication of acquired immunodeficiency syndrome: report of the National Heart, Lung, and Blood Institute workshop. N Engl J Med. 1984;310:1682-1688.
6. Baggot LA, Baggot BB. Pneumocystis carinii pneumonia in AIDS patients in intensive care [abstract]. Chest. 1987;92(suppl):132S.
7. Staikowsky F, Lafon B, Guidet B, et al. Mechanical ventilation for pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome: is the prognosis really improved? Chest. 1993;104:756-762.
8. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
9. Murphy EL, Collier AC, Kalisk LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135:17-26.
10. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450-454.
11. Afessa B, Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in ICU. Chest. 2000;118:138-145.
12. Wachter R, Luce JM, Hopewell PC. Critical care of patients with AIDS. JAMA. 1992;267:541-547.
13. Curtis JR, Marquis KA. Care for the patient with AIDS in the ICU: outcome and ethics. Clin Pul Med. 1996;3:271-278.
14. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(RR-17):1-19.
15. Nickas G, Wachter RM. Outcome of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med. 2000;160:541-547.
16. Rogers PL, Lane HC, Henderson DK, et al. Admission of AIDS patients to a medical intensive care unit: causes and outcome. Crit Care Med. 1989;17:113-117.
17. Rosenberg AL, Seneff MG, Atiyeh L, et al. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance. Crit Care Med. 2001;29:548-556.
18. Narasimhan M, Posner AJ, DePalo VA, et al. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest. 2004;125:1800-1804.
19. Curtis JR, Bennett CL, Horner RD, et al. Variations in intensive care unit utilization for patients with human immunodeficiency virus related peumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med. 1998;26:668-675.
20. Morris A, Creasman J, Turner J, et al. Intensive care of HIV-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med. 2002;166:262-267.
21. Rhone SA, Hoggs RS, Yip B, et al. Do dual nucleoside regimens have a role in an era of plasma viral load driven antiretroviral therapy? J Infect Dis. 1998;178:662-668.
22. Havlir DV, Marschner IC, Hirsch MS, et al. Maintenance antiretroviral therapies in HIV infected subjects with undetectable plasma HIV RNA after triple drug therapy. N Engl J Med. 1998;339:1261-1268.
23. Carpenter C, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998: update recommendations of the International AIDS Society-USA Panel. JAMA. 1998;280:78-86.
24. Hirsch MS, Conway B, D'Aquila RT, et al. Antiretroviral drug resistance testing in HIV infection of adults: implications for clinical management. JAMA. 1998;279:1984-1991.
25. Gunthard H, Wong J, Ignacio C, et al. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J Virol. 1998;72:2422-2428.
26. Walmsely S, Bernstein B, King M, et al. Lopinavir-Ritonavir versus Nelfinavir for the initial treatment of HIV infection. N Engl J Med. 2002;346:2039-2046.
27. Wolff AJ, O'Donnell AE. Pulmonary manifestation of HIV infection in the era of highly active antiretroviral therapy. Chest. 2001;120:1888-1893.
28. Curtis JR, Yarnold PR, Schwartz DN, et al. Improvement in outcomes of acute respiratory failure for patients with human immunodeficiency virus related pneumocystis carinii pneumonia. Am J Respir Crit Med. 2000;162:393-398.
29. Luce JM, Stover DE. Controversies in pulmonary medicine: presumed PCP should be treated in patients with the acquired immunodeficiency syndrome. Pro and con. Am Rev Respir Dis. 1988;138:1076-1077.
30. Raoof S, Rosen M. Role of bronchoscopy in AIDS. Clinics in Chest. 1999;20:65.
31. Vella S, Chiesi A, Volpi A, et al. Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions. JAMA. 1994;271:1197-1199.
32. Mendelson MH, Gurtman A, Szabo S, et al. Pseudomonas aeruginosa in patients with AIDS. Clin Infect Dis. 1994;18:886-895.
33. Lazard T, Retel O, Guidet B, et al. AIDS in medical intensive care unit: immediate prognosis and long-term long term survival. JAMA. 1996;276:1240-1245.
34. Casalino E, Mendoza-Sassi G, Wolff M, et al. Predictors of short- and long-term survival in HIV infected patients admitted to the ICU. Chest. 1998;113:421-429.
35. Schein RM, Fischl MA, Pitchenick AE, et al. ICU survival of patients with acquired immunodeficiency syndrome. Crit Care Med. 1986;14:1026-1027.